Prescription-data provider IMS Health Holdings Inc. said late Thursday that it has priced its initial public offering at $20 a share, raising $1.3 billion in the second-largest IPO in the U.S. so far this year.. The Danbury, Conn.-based company and some of its existing investors—the Canada Pension Plan Investment Board and private-equity firms TPG Capital and Leonard Green & Partners LP—sold a total of 65 million shares in the offering. The IPO was priced toward the high end of an expected range of $18 a share to $21 a share.